Toragen, Inc.
PrivateLast Round
Convertible Debt
Sep 30, 2025
Total Funding Raised
$17.4M
Company Overview
Toragen, Inc. is a clinical-stage biotechnology company that develops novel small molecule inhibitors to treat cancers caused by the human papillomavirus (HPV).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Toragen, Inc. Comparables
Compare Toragen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kovina Therapeutics | 84% | |
| Flow Pharma, Inc. | 73% | |
| PapiVax Biotech, Inc. | 72% | |
Toragen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 30, 2025 | ||||
| Seed | Sep 30, 2022 |
Toragen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Convertible Debt |
| The Raptor Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 57% MoM.
- Jun 1, 2025
Monthly visitors increased 143% MoM, reaching 705.
Toragen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Toragen, Inc.'s valuation, stock price, and market status.